Created in 1990 as an INSERM spin-off, CEMKA is one of the leading consulting companies in medical product evaluation: medicines, vaccines, devices, health programmes and organisations.
CEMKA’s activities cover a wide range of fields: health economics (PROMs, PREMs, modelling, etc.), production and analysis of primary and secondary data, market access dossier including strategic consulting, surveys and value dossiers.
The expertise developed by CEMKA is widely recognised, nationally and internationally, as demonstrated by the diversity of its clients (health authorities, health insurance companies, pharmaceutical and biomedical industries, patients’ and professional associations, health providers, academic structures, etc.) and the extent of its peer-reviewed publications.
